StonvexLoading…
StonvexStonvexStonvexCore line items from CWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.10M | $15.20M | $11.20M | $7.70M |
Operating Income | $-5.93M | $-23.03M | $-14.97M | $-10.25M |
Net Income | $-3.62M | $-21.80M | $-14.08M | $-9.71M |
EPS (Diluted) | $-0.52 | $-7.70 | $-8.31 | $-8.00 |
Total Assets | $179.59M | $135.40M | $82.57M | $59.26M |
Total Liabilities | $140.88M | $109.17M | $76.48M | $76.86M |
Cash & Equivalents | $931.00K | $2.86M | $10.93M | $683.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 7.00M | 2.83M | 1.69M | 1.21M |